Former Allergan Exec Carrie Strom Named CEO of Hugel Following U.S. Launch of Letybo

Carrie Strom’s appointment signals Hugel’s ambition to accelerate growth across the Americas and other key international markets.
Carrie Strom’s appointment signals Hugel’s ambition to accelerate growth across the Americas and other key international markets.
Courtesy of Pacharee at Adobe Stock

Carrie Strom, the former vice president of Allergan Aesthetics, has been appointed as president and CEO of Hugel, the South Korea-based brand that manufactures Letybo, a botulinum toxin injectable. This transition, as of Oct. 13, follows Hugel’s rollout of Letybo in the U.S. in May 2025. 

Log in to view the full article
More in Companies